Leukemia, Myeloid, Acute: all 3,035 studies
Page 22 of 31. Open to participants first (746), then studies with results posted, then the rest; newest registration first within each.
- Clinical Trial of OPB-111077 in Patients With Relapsed or Refractory Acute Myeloid LeukaemiaCompletedNCT03197714Phase 1
- Study of Venetoclax in Combination With Chemotherapy in Pediatric Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Leukemia of Ambiguous LineageCompletedNCT03194932Phase 1
- Study of FF-10101-01 in Patients With Relapsed or Refractory Acute Myeloid LeukemiaCompletedNCT03194685Phase 1
- Study Evaluating Safety and Efficacy of UCART123v1.2 in Patients With Relapsed/Refractory Acute Myeloid LeukemiaActive, not recruitingNCT03190278Phase 1
- Study of CFI-400945 Fumarate in Patients With Relapsed or Refractory AML or MDSCompletedNCT03187288Phase 1
- Cladribine in Combination With CAG in Patients With Refractory/Relapsed Acute Myeloid LeukemiaStatus unknownNCT03181815Phase 2
- High-Intensity Parent Intervention Program in Improving Learning and School Functioning in Latino Children With Acute Leukemia or Lymphoblastic LymphomaActive, not recruitingNCT03178617Not applicable
- The Efficiency of CAMS (Chinese Academy of Medical Sciences)-2016 Trial for Pediatric Acute Myeloid LeukemiaStatus unknownNCT03173612Not applicable
- Efficacy Analysis of Comparison of CAMS（Chinese Academy of Medical Sciences）-2005 Trial and CAMS-2009 Trial for Pediatric Acute Myeloid LeukemiaCompletedNCT03165851
- A Trial of Epigenetic Priming in Patients With Newly Diagnosed Acute Myeloid LeukemiaActive, not recruitingNCT03164057Phase 2
- Early Tapering of Immunosuppressive Agents to Immunomodulation to Improve Survival of AML PatientsStatus unknownNCT03150134Phase 4
- Changes in the Gut Microbiota of Patients Undergoing Allogeneic Stem Cell Transplantation (COLLECT)Status unknownNCT03148197
- Study of AMV564 in Patients With AMLCompletedNCT03144245Phase 1
- Palbociclib and Sorafenib, Decitabine, or Dexamethasone in Treating Patients With Recurrent or Refractory LeukemiaActive, not recruitingNCT03132454Phase 1
- BAY1436032 in Patients With Mutant IDH1(mIDH1) Advanced Acute Myeloid Leukemia (AML)CompletedNCT03127735Phase 1
- Study of Adoptive Cellular Therapy Using Autologous T Cells Transduced With Lentivirus to Express a CD33 Specific Chimeric Antigen Receptor in Patients With Relapsed or Refractory CD33-Positive Acute Myeloid LeukemiaTerminatedNCT03126864Phase 1
- A Phase Ib Study of CT053PTSA in Relapsed / Refractory Acute Myeloid Leukemia (AML)TerminatedNCT03125876Phase 1
- Combination Merestinib and LY2874455 for Patients With Relapsed or Refractory Acute Myeloid LeukemiaCompletedNCT03125239Phase 1
- Study of Intensity Modulated Total Marrow Irradiation (IM-TMI) in Addition to Fludarabine/Busulfan Conditioning for Allogeneic Transplantation in High Risk AML and Myelodysplastic SyndromesActive, not recruitingNCT03121014Phase 2
- Donor-derived Anti-CD123-CART Cells for Recurred AML After Allo-HSCTStatus unknownNCT03114670Phase 1
- An Expanded Treatment Protocol (ETP) of Midostaurin (PKC412) in Patients 18 Years of Age or Older With Newly-diagnosed FLT3-mutated Acute Myeloid Leukemia (AML)No longer availableNCT03114228
- Gluten Free Diet in Diminishing Side Effects Patients With Acute Myeloid Leukemia Undergoing Induction ChemotherapyTerminatedNCT03108911Phase 2
- A Multiple Ascending Dose Study of MEDI7247 in Patients With Selected Relapsed/Refractory Hematological MalignanciesCompletedNCT03106428Phase 1
- Haploidentical Stem Cell Transplantation Using Post-Transplant CyclophosphamideTerminatedNCT03088709Phase 2
- Cellular Immunotherapy for Patients With High Risk Myelodysplastic Syndromes and Acute Myeloid LeukemiaStatus unknownNCT03083054Phase 1/2
- Open Label NK Cell Infusion (FATE-NK100) With Subq IL-2 in Adults With AMLCompletedNCT03081780Phase 1
- The Use of Decitabine as Induction Therapy for Acute Myeloid Leukemia With Complex and/or Monosomal KaryotypeStatus unknownNCT03080766Phase 2
- Expanded Access Study of Gilteritinib (ASP2215) in Patients With FMS-like Tyrosine Kinase 3 (FLT3) Mutated Relapsed or Refractory Acute Myeloid Leukemia (AML) or FLT3-Mutated AML in Complete Remission (CR) With Minimal Residual Disease (MRD)Approved for marketingNCT03070093
- Study of PDR001 and/or MBG453 in Combination With Decitabine in Patients With AML or High Risk MDSCompletedNCT03066648Phase 1
- Randomized Study: Standard of Care With or Without Atorvastatin for Prevention of GVHD for Matched Unrelated Donor BMTWithdrawnNCT03066466Phase 3
- STAT Inhibitor OPB-111077, Decitabine and Venetoclax in Treating Patients With Acute Myeloid Leukemia That Is Refractory, Relapsed or Newly Diagnosed and Ineligible for Intensive ChemotherapyCompletedNCT03063944Phase 1
- A Phase 2a, Open-Label, Two Stage Study of Nerofe or Nerofe With Doxorubicin in Subjects With AML or MDSWithdrawnNCT03059615Phase 2
- DC/AML Fusion Cell Vaccine vs Observation in Patients Who Achieve a Chemotherapy-induced RemissionActive, not recruitingNCT03059485Phase 2
- Clinical Study of CWP232291 in Acute Myeloid Leukemia PatientsTerminatedNCT03055286Phase 1/2
- A Prospective, Interventional Study Assessing Response to Cytarabine, Daunorubicin and Etoposide (ADE) for First Relapse of Paediatric Acute Myeloid LeukemiaStatus unknownNCT03053206Phase 2
- Treatment Patterns and Key Healthcare Resource Use in Acute Myeloid Leukemia (AML) With or Without FMS-like Tyrosine Kinase-3 (FLT3) Mutation Study Based on Retrospective Chart ReviewCompletedNCT03047083
- Clinical Trial of Ara-C, Aclarubicin Combined With PEG-G-CSF for Initial Treatment of AML PatientsStatus unknownNCT03045627Phase 2
- Study of Regorafenib in Patients With Advanced Myeloid MalignanciesCompletedNCT03042689Phase 1
- Testing a New Chemotherapy Drug, KRT-232 (AMG-232) in Combination With Decitabine and Venetoclax in Patients With Acute Myeloid LeukemiaActive, not recruitingNCT03041688Phase 1
- MCLA-117 in Acute Myelogenous LeukemiaTerminatedNCT03038230Phase 1
- Sequential Conditioning in Haploidentical Transplantation for Refractory Acute Myeloid LeukemiaCompletedNCT03035422Not applicable
- A Study of ARGX-110 in Combination With Azacytidine in Participants With Newly Diagnosed Acute Myeloid Leukemia (AML) or High Risk Myelodysplatic Syndrome (MDS)CompletedNCT03030612Phase 1/2
- Study of Allogeneic Double Negative T Cells (DNT-UHN-1) in Patients With High Risk Acute Myeloid LeukemiaCompletedNCT03027102Phase 1
- Decitabine Versus Conventional Chemotherapy for Maintenance Therapy of Acute Myeloid Leukemia With t(8;21)Status unknownNCT03026842Phase 4
- Feasibility Study of Intermediate Doses of ARA-C With Autologous SCT as Consolidation of Low/Intermediate-risk AMLStatus unknownNCT03023384
- Pevonedistat and Decitabine in Treating Patients With High Risk Acute Myeloid LeukemiaCompletedNCT03009240Phase 1
- Haploidentical BMT With Post-Transplant Cyclophosphamide and BendamustineCompletedNCT02996773Phase 1
- CX-01 Combined With Azacitidine in the Treatment of Relapsed or Refractory Myelodysplastic Syndrome and Acute Myeloid LeukemiaCompletedNCT02995655Phase 1
- Single Agent JNJ-56022473 in MDS and AML Patients FAILING HYPOMETHYLATING AGENT BASED THERAPYTerminatedNCT02992860Phase 2
- Italian Registry on the Prevalence of IDH1/IDH2 Mutations in Patients With Acute Myeloid LeukemiaCompletedNCT02986620
- Decitabine in Combination With Low-dose Cytarabine in Elderly Patients With Acute Myeloid LeukemiaStatus unknownNCT02985372Phase 3
- Phase I Study of S64315 Administred Intravenously in Patients With Acute Myeloid Leukaemia or Myelodysplastic SyndromeCompletedNCT02979366Phase 1
- A Collaborative Palliative and Oncology Care Model for Patients With Acute Myeloid LeukemiaCompletedNCT02975869Not applicable
- Engineered Donor Stem Cell Transplant in Treating Patients With Hematologic MalignanciesCompletedNCT02960646Phase 1
- The Oronasal Microbiota in Pediatric Oncology PatientsCompletedNCT02949427
- CAR-pNK Cell Immunotherapy for Relapsed/Refractory CD33+ AMLStatus unknownNCT02944162Phase 1/2
- A Study Evaluating Venetoclax in Combination With Azacitidine in Participants With Treatment-Naïve Higher-Risk Myelodysplastic Syndromes (MDS)CompletedNCT02942290Phase 1
- Risk Stratification-directed Therapy for AML With t(8;21) /AML1-ETO+CompletedNCT02936089Not applicable
- PreventiOn of DYSbioSis Complications With Autologous FMT in AML PatientsCompletedNCT02928523Phase 1/2
- Beat AML Core StudyCompletedNCT02927106
- Fludarabine and Cytarabine Versus High-dose Cytarabine for CBF-AMLCompletedNCT02926586Phase 4
- Clinical Trial of BP1001 (Liposomal Grb2 Antisense Oligonucleotide) in Combination With Dasatinib in Patients With Ph + CML Who Have Failed TKI, Ph+ AML, Ph+ MDSWithdrawnNCT02923986Phase 1/2
- A Study to Analyze the Occurrence of Transformation From Myelodysplastic Syndrome to Acute Myeloid Leukemia in Patients With Myelodysplastic Syndrome Who Received Revlimid® 5 mg Capsules and Who Are Continuing or no Longer Continuing Revlimid TreatmentCompletedNCT02921815
- Dose-escalation Study of Oral Administration of S 055746 in Patients With Acute Myeloid Leukaemia or Myelodysplastic SyndromeCompletedNCT02920541Phase 1
- Safety Study of ALRN-6924 in Patients With Acute Myeloid Leukemia or Advanced Myelodysplastic SyndromeCompletedNCT02909972Phase 1
- Volasertib Combined With Induction Chemotherapy in Acute Myeloid LeukemiaWithdrawnNCT02905994Phase 1
- Invasives Aspergillosis in Acute Myeloid LeukemiaCompletedNCT02900430
- Transfusion in Adult Acute Myeloid LeukemiaCompletedNCT02899767
- Efficacy and Safety Study of Recombinant Human Arginase 1 in Patients With Relapsed or Refractory Acute Myeloid LeukemiaStatus unknownNCT02899286Phase 2
- Infection and Tumour Antigen Cellular TherapyStatus unknownNCT02895412Phase 1
- A Study Evaluating the Safety and Pharmacology of Atezolizumab Administered in Combination With Immunomodulatory Agents in Participants With Acute Myeloid Leukemia (AML)CompletedNCT02892318Phase 1
- An Observational Post Authorisation Study to Evaluate Safety and Efficacy in Patients Receiving Azacitidine in Daily Clinical Practice in the NetherlandsCompletedNCT02891551
- Sertraline and Cytosine Arabinoside in Adults With Relapsed and Refractory AMLCompletedNCT02891278Phase 1
- King's Invasive Aspergillosis Study IICompletedNCT02875743Phase 4
- Ph 1 Study of ADI-PEG 20 Plus Low Dose Cytarabine in Older Patients With AMLTerminatedNCT02875093Phase 1
- MRD-directed Therapy for Low-risk and Intermediate-risk AML.CompletedNCT02870777Phase 2/3
- A Study to Evaluate Escalating Doses of ASP1235 (AGS62P1) Given as Monotherapy in Subjects With Acute Myeloid Leukemia (AML)TerminatedNCT02864290Phase 1
- Reflexology: An Intervention for Acute Myeloid Leukemia(AML) PatientsStatus unknownNCT02863302Not applicable
- Busulfan, Fludarabine Phosphate, and Post-Transplant Cyclophosphamide in Treating Patients With Blood Cancer Undergoing Donor Stem Cell TransplantActive, not recruitingNCT02861417Phase 2
- Role of PTK-7 in Acute Myeloid LeukemiasCompletedNCT02860793Not applicable
- A Study of SKLB1028 in Subjects With Relapsed/Refractory Acute Myeloid LeukemiaStatus unknownNCT02859948Phase 1
- Prophylactic DLI for the Prevention of Relapse Post HSCT in Patients With High Risk Myeloid MalignancyStatus unknownNCT02856464Phase 2
- Shotgun Sequencing in Diagnosing Febrile Neutropenia in Patients With Acute Myeloid LeukemiaCompletedNCT02856204
- Study on Safety and Pharmacokinetics of Intravenous F901318 for Fungal Prophylaxis in AML PatientsWithdrawnNCT02856178Phase 1/2
- A Safety Study of SGN-CD123A in Patients With Acute Myeloid LeukemiaTerminatedNCT02848248Phase 1
- Optimal Treatment Strategy Based on for Pediatric AMLStatus unknownNCT02848183Phase 2
- Economic Analysis of Blood Product Transfusions According to the Treatment of Acute Myeloid Leukaemia in the ElderlyCompletedNCT02845232
- Transfusion Dependency at Diagnosis and Transfusion Intensity During Initial Chemotherapy Are Associated With Poorer Outcomes in Adult Acute Myeloid LeukaemiaCompletedNCT02844257
- Effect of Age on Treatment Decision-Making in Elderly Patients With Acute Myeloid LeukemiaCompletedNCT02844218
- Higher Percentage of CD34+ CD38- Cells Detected by Multiparameter Flow Cytometry From Leukapheresis Products Predicts Unsustained Complete Remission in Acute Myeloid LeukemiaCompletedNCT02842112
- A Study of H3B-8800 (RVT-2001) in Participants With Lower Risk Myelodysplastic SyndromesTerminatedNCT02841540Phase 1
- A Study of Indoximod in Combination With (7+3) Chemotherapy in Patients With Newly Diagnosed Acute Myeloid LeukemiaCompletedNCT02835729Phase 1
- Microtransplantation in Older Patients With Acute Myeloid LeukemiaCompletedNCT02831192Phase 2
- Dose-Escalation Study of Ponatinib, a FLT3 Inhibitor, With and Without Combination of 5-Azacytidine, in Patients With FLT3-Mutated Acute Myeloid Leukemia (AML)WithdrawnNCT02829840Phase 1/2
- A Dose Finding Study of IDH305 With Standard of Care in IDH1 Mutant Acute Myeloid LeukemiaWithdrawnNCT02826642Phase 1
- Interleukin-21 (IL-21)- Expanded Natural Killer Cells for Induction of Acute Myeloid LeukemiaStatus unknownNCT02809092Phase 1/2
- Efficacy Study of Inecalcitol With Decitabine in Acute Myeloid Leukemia Patients Unfit for Standard ChemotherapyStatus unknownNCT02802267Phase 2
- GVHD Prophylaxis With Post-transplantation Bendamustine in Refractory LeukemiaCompletedNCT02799147Phase 1/2
- Pharmacological Study of Intravenous OTS167 in Patients With Refractory or Relapsed Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Advanced Myelodysplastic Syndromes, Advanced Myeloproliferative Neoplastic Disorders, or Advanced Chronic Myelogenous LeukemiaTerminatedNCT02795520Phase 1/2
- Wee1 Kinase Inhibitor AZD1775 and Combination Chemotherapy in Treating Children, Adolescents and Young Adults With Relapsed or Refractory Acute Myeloid LeukemiaWithdrawnNCT02791919Phase 1